Table 2 Comparison of DHEAS levels between different groups of COVID-19 patients with and without hypertension and healthy participants (control).

From: Association of DHEAS levels with COVID19 severity, gender, age, comorbidities, and management strategies

 

DHEAS (µg/dL)

N

Mean ± SD

Median

Q1

Q3

p.value1

p.value2

p.value3

p.value4

1

HTN Positive/ Patient

158

77.23 ± 72.28

53.90

20.70

104.00

    

2

HTN Negative / Patient

443

110.02 ± 90.10

87.00

44.00

150.00

< 0.001

   

3

HTN Negative / Control

65

118.20 ± 103.35

79.40

48.20

165.00

0.002

0.483

  

1

HTN Positive / Inpatient

120

74.82 ± 71.90

48.00

20.80

103.00

    

2

HTN Positive / Outpatient

38

84.86 ± 73.91

71.95

19.50

122.00

0.529

   

3

HTN Negative / Inpatient

229

87.39 ± 76.47

65.10

33.40

115.00

0.193

0.866

  

4

HTN Negative/ Outpatient

214

134.23 ± 97.19

115.00

62.80

186.00

< 0.001

0.001

< 0.001

 

5

HTN Negative / Control

65

118.20 ± 103.35

79.40

48.20

165.00

0.001

0.057

0.011

0.187

1

HTN Positive / patient

Female

88

60.08 ± 61.74

29.25

15.60

72.15

    

Male

70

98.79 ± 78.95

79.00

41.70

130.00

0.001

   

2

HTN Negative / patient

Female

167

84.99 ± 74.40

67.80

36.80

116.00

    

Male

276

125.16 ± 95.37

103.50

52.10

174.00

< 0.001

   

3

HTN Negative / control

Female

24

68.70 ± 52.86

56.85

24.80

88.70

    

Male

41

147.17 ± 114.69

99.60

54.80

222.00

0.002

   
  1. P-value 1 compares group1 with other groups and p-value 2 compares group 2 with other groups. P-value 3 compares group 3 with other groups. P-value 4 compares group 4 with group 5. P-value < = 0.05 is significant.
Back to article page